Literature DB >> 10227684

On the front of X-linked adrenoleukodystrophy.

P Aubourg1.   

Abstract

The profound and lasting involvement of Hugo and Ann Moser have allowed to make remarkable progress in adrenoleulodystrophy (ALD) during the last 20 years. Besides their own commitment in ALD, Hugo and Ann have constantly encouraged physicians, biologists and molecular geneticists to undertake clinical and fundamental research in this devastating disease. There is now some preventive and therapeutic approaches which can be proposed to ALD patients and families. The issues that still remain unresolved will certainly keep busy those who share the "Hugo and Ann spirit".

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227684     DOI: 10.1023/a:1022583813171

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.

Authors:  V Feigenbaum; G Lombard-Platet; S Guidoux; C O Sarde; J L Mandel; P Aubourg
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  X-linked adrenoleukodystrophy: the Australasian experience.

Authors:  E P Kirk; J M Fletcher; P Sharp; B Carey; A Poulos
Journal:  Am J Med Genet       Date:  1998-04-13

3.  Topographical localization of peroxisomal acyl-CoA ligases: differential localization of palmitoyl-CoA and lignoceroyl-CoA ligases.

Authors:  O Lazo; M Contreras; I Singh
Journal:  Biochemistry       Date:  1990-04-24       Impact factor: 3.162

4.  Identification of a fourth half ABC transporter in the human peroxisomal membrane.

Authors:  N Shani; G Jimenez-Sanchez; G Steel; M Dean; D Valle
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

5.  Retroviral transfer and long-term expression of the adrenoleukodystrophy gene in human CD34+ cells.

Authors:  N Doerflinger; J M Miclea; J Lopez; C Chomienne; P Bougnères; P Aubourg; N Cartier
Journal:  Hum Gene Ther       Date:  1998-05-01       Impact factor: 5.695

6.  Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.

Authors:  L T Braiterman; S Zheng; P A Watkins; M T Geraghty; G Johnson; M C McGuinness; A B Moser; K D Smith
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

7.  Mutations in the gene for X-linked adrenoleukodystrophy in patients with different clinical phenotypes.

Authors:  A Braun; H Ambach; S Kammerer; B Rolinski; S Stöckler; W Rabl; J Gärtner; S Zierz; A A Roscher
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

8.  Gene redundancy and pharmacological gene therapy: implications for X-linked adrenoleukodystrophy.

Authors:  S Kemp; H M Wei; J F Lu; L T Braiterman; M C McGuinness; A B Moser; P A Watkins; K D Smith
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

9.  Mutations in the 70K peroxisomal membrane protein gene in Zellweger syndrome.

Authors:  J Gärtner; H Moser; D Valle
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

10.  The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications.

Authors:  J M Powers; Y Liu; A B Moser; H W Moser
Journal:  J Neuropathol Exp Neurol       Date:  1992-11       Impact factor: 3.685

View more
  1 in total

Review 1.  Therapy of adrenal insufficiency: an update.

Authors:  Alberto Falorni; Viviana Minarelli; Silvia Morelli
Journal:  Endocrine       Date:  2012-11-21       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.